Carlyle Group’s Molecular Templates, Inc. MTEM Stock Holding History

Carlyle Group’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,333	Closed	-$18.7K	–	31
2024 Q3	$18.7K	Hold	13,333	–	–	﹤0.01%	26
2024 Q2	$14.8K	Hold	13,333	–	–	﹤0.01%	31
2024 Q1	$28.7K	Hold	13,333	–	–	﹤0.01%	32
2023 Q4	$49.3K	Hold	13,333	–	–	﹤0.01%	25
2023 Q3	$84.3K	Hold	13,333	–	–	﹤0.01%	25
2023 Q2	$92K	Hold	13,333	–	–	﹤0.01%	26
2023 Q1	$75K	Buy	+13,333	New	+$90K	﹤0.01%	29

Other funds holding MTEM

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Carlyle Group's MTEM Position: Q4 2024 in Review

Carlyle Group sold out of Molecular Templates, Inc. (MTEM) in Q4 2024, closing a stake of 13,333 shares — an estimated $18.7K sold.

Carlyle Group first reported a position in MTEM in Q1 2023 and held it in 7 quarters. The position peaked at $92K in Q2 2023. 3 funds tracked by Wall St. Rank hold MTEM as of Q4 2024.

Carlyle Group reported no remaining Molecular Templates, Inc. position as of Q4 2024 after selling out during the quarter.
Carlyle Group sold 13,333 Molecular Templates, Inc. shares in Q4 2024, an estimated $18.7K.
Carlyle Group first reported a position in Molecular Templates, Inc. in Q1 2023 and held it in 7 quarters.
Carlyle Group's Molecular Templates, Inc. position peaked at $92K in Q2 2023.
3 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2024.

Based on Carlyle Group's 13F filing for Q4 2024, filed 13 Feb 2025.